PMP Statute Requirements
Public Act 100-0564 was enacted by the Illinois General Assembly and became effective on January 1, 2018. This law made significant changes to help strengthen Illinois Prescription Monitoring Program to aid prescribers when making clinical decisions. Illinois General Assembly - FullText Illinois Controlled Substances Act.
Mandatory Dispenser Reporting
Each time a Schedule II-V drug or other selected drugs, as described in Section 2080.230, is dispensed, the dispenser must transmit electronically by the end of the business day. If no Schedule II-V drug or other selected drugs, as described in Section 2080.230, is dispensed, the dispenser must transmit a zero report. For hospitals licensed under the Hospital Licensing Act [210 ILCS 85], any discharge or outpatient prescription exceeding a 72-hour quantity must be reported to the ILPMP central repository no later than the end of the business day.
Error Reporting
If a prescriber notices an error in their prescription information, they shall report it to the dispensing pharmacy within 7 days after discovery of the error. A dispenser who notices an error in a prescription they have dispensed and transmitted shall retract the incorrect prescription and retransmit the prescription correctly within 7 days after discovery of the error.
Mandatory ILPMP registration
Prescribers must register for an ILPMP account on ILPMP.org when possessing an Illinois Controlled Substance license.
Authority to designate designee.
Prescribers and pharmacists who are registered with ILPMP may authorize designees to access ILPMP data on their behalf.
Utilization of ILPMP
Each prescriber or his or her designee shall also document an attempt to access patient information in the Prescription Monitoring Program to assess patient access to controlled substances when providing an initial prescription for Schedule II narcotics such as opioids, except for prescriptions for oncology treatment or palliative care, or a 7-day or less supply provided by a hospital emergency department when treating an acute, traumatic medical condition. This attempt to access shall be documented in the patient's medical record.
Mandated Electronic Health Record (EHR) and Pharmacy Management Systems integration to have access to State of Illinois PMPnow.
All EHR and Pharmacy Management Systems in Illinois must interface with ILPMP. This will allow providers to access ILPMP data within the prescriber’s clinical workflow.
Opioid Treatment Programs, with patient consent, to report data to ILPMP.
OTP reporting to ILPMP will allow for better coordination of care among treating providers.
COVID-19 Resources
This section provides informational links for State of Illinois and federal guidelines and resources on COVID-19 and related topics.
Legislation and Regulations
This section includes links to relevant Illinois statutes, rules, and state/federal policies that govern controlled substances, pharmacy practice, and electronic prescription monitoring in Illinois. These resources help ensure compliance with legal requirements.
Controlled Substances
This section provides federal resources that outline how controlled substances are classified, handled, prescribed, and monitored. The links offer guidance from the DEA for pharmacists and prescribers on proper storage, recordkeeping, dispensing, and legal responsibilities related to controlled substances.